Eamon Drugs Private Limited - Company Profile

It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 1985.
1985 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Eamon Drugs Private Limited

Eamon Drugs Private Limited, a active private limited company, was established on 04 September 1985 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24114MP1985PTC003021. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹7.24 M.

Formerly known as Shyra Chemicals Private Limited, Midway Drugs Private Limited. It upholds a compliant status. Employing 18 professional, Its leadership includes Mahendra Kumar Mandloi (Director), Rishabh Mandloi (Director), Udit Sodani (Director). Past directors included Ayush Kabra, Harish Gangwani, Rishabh Mandloi. It holds ₹4.20 Cr open charges and ₹2.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 104-A-2 105 A-1 Sect E Sanwer Road, Indore, Madhya Pradesh, 452001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24114MP1985PTC003021

  • Registration Number

    003021

  • Incorporation Date

    04 September 1985

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹7.24 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 7.24 M
  • Company Age 40 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.20 Cr
  • Satisfied Charges ₹ 2.00 Cr
  • Revenue Growth **** 20.39%
  • Profit Growth **** 31.87%
  • Ebitda **** 11.48%
  • Net Worth 15.30%
  • Total Assets **** 29.08%
Company report

Eamon Drugs Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Eamon Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Eamon Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Mahendra Kumar Mandloi Director 25 Jan 2018 Current
Rishabh Mandloi Director 14 Jul 2020 Current
Udit Sodani Director 25 Jan 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Jan 2018 Past
Pramod Abcsdd Additional Director 29 Jan 2018 Past
Pramod Abcsdd Director 27 Dec 2020 Past
Pramod Abcsdd Director 16 May 2023 Past
Pramod Abcsdd Additional Director 25 Jan 2018 Past
Pramod Abcsdd Additional Director 25 Jan 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eamon Drugs.

Eamon Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.39% increase. The company also saw a substantial improvement in profitability, with a 31.87% increase in profit. The company's net worth Soared by an impressive increase of 15.3%.

Eamon Drugs revenue growth over time
Eamon Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 20.39%
*******
*******
*******
*******
Revenue from Operations
*******
 20.40%
*******
*******
*******
*******
Total Assets
*******
 29.08%
*******
*******
*******
*******
Profit or Loss
*******
 31.87%
*******
*******
*******
*******
Net Worth
*******
 15.30%
*******
*******
*******
*******
EBITDA
*******
 11.48%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eamon Drugs?

In 2023, Eamon Drugs had a promoter holding of 76.00% and a public holding of 24.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹42,000,000.00

Satisfied Charges

₹20,000,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 4.00 Cr
  • Others : 0.20 Cr
Latest Charge Details
Date Lender Amount Status
12 Nov 2025 Canara Bank ₹4.00 Cr Open
11 Oct 2024 Others ₹2.00 M Open
07 Mar 2023 Others ₹2.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Eamon Drugs?

Eamon Drugs has a workforce of 18 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eamon Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eamon Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eamon Drugs
Recent Activity within the Organization
  • Charges

    The activity A charge with Canara Bank amounted to Rs. 4.00 Cr with Charge ID 101193335 was registered on 12 Nov 2025. was completed.

  • Charges

    A charge registered on 07 Mar 2023 via Charge ID 100685182 with Others was fully satisfied on 12 Nov 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Eamon Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Eamon Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100995985 was registered on 11 Oct 2024. was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100685182 was registered on 07 Mar 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Eamon Drugs Private Limited?

The CIN of Eamon Drugs Private Limited is U24114MP1985PTC003021.

Where is Eamon Drugs Private Limited headquartered?

Eamon Drugs Private Limited is headquartered at 104-A-2 105 A-1 Sect E Sanwer Road, Indore, Madhya Pradesh, 452001.

When was Eamon Drugs Private Limited incorporated?

Eamon Drugs Private Limited was incorporated on 04 September 1985.

Who are the current directors of Eamon Drugs Private Limited?

The current directors of Eamon Drugs Private Limited are

What is the primary industry of Eamon Drugs Private Limited?

The primary industry of Eamon Drugs Private Limited is Manufacturing.

Is Eamon Drugs Private Limited a listed company?

Eamon Drugs Private Limited is unlisted.

What is the capital structure of Eamon Drugs Private Limited?

The authorized capital of Eamon Drugs Private Limited is ₹1.00 Cr, and the paid-up capital is ₹7.24 M.

What is the compliance status of Eamon Drugs Private Limited?

The compliance status of Eamon Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available